A1ENX

[2-[[4-(1,3-benzothiazol-5-yl)-5-fluoranyl-pyrimidin-2-yl]amino]-1,3-thiazol-5-yl]-piperazin-1-yl-methanone

Created:	2025-03-22
Last modified:	2026-03-25

Find Related PDB Entry
1 entries where A1ENX is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	46
Chiral Atom Count	0
Bond Count	50
Aromatic Bond Count	21

2D diagram of A1ENX

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	[2-[[4-(1,3-benzothiazol-5-yl)-5-fluoranyl-pyrimidin-2-yl]amino]-1,3-thiazol-5-yl]-piperazin-1-yl-methanone
Systematic Name (OpenEye OEToolkits)	[2-[[4-(1,3-benzothiazol-5-yl)-5-fluoranyl-pyrimidin-2-yl]amino]-1,3-thiazol-5-yl]-piperazin-1-yl-methanone
Formula	C₁₉ H₁₆ F N₇ O S₂
Molecular Weight	441.505
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	Fc1cnc(Nc2sc(cn2)C(=O)N3CCNCC3)nc1c4ccc5scnc5c4
SMILES	OpenEye OEToolkits	2.0.7	c1cc2c(cc1c3c(cnc(n3)Nc4ncc(s4)C(=O)N5CCNCC5)F)ncs2
Canonical SMILES	CACTVS	3.385	Fc1cnc(Nc2sc(cn2)C(=O)N3CCNCC3)nc1c4ccc5scnc5c4
Canonical SMILES	OpenEye OEToolkits	2.0.7	c1cc2c(cc1c3c(cnc(n3)Nc4ncc(s4)C(=O)N5CCNCC5)F)ncs2
InChI	InChI	1.06	InChI=1S/C19H16FN7OS2/c20-12-8-22-18(25-16(12)11-1-2-14-13(7-11)24-10-29-14)26-19-23-9-15(30-19)17(28)27-5-3-21-4-6-27/h1-2,7-10,21H,3-6H2,(H,22,23,25,26)
InChIKey	InChI	1.06	OEDROIFJDAHTCX-UHFFFAOYSA-N

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.